Form D · Other

Triwood Capital Corp

Calgary, A0 · CIK 0001518539

Offering snapshot reported Apr 22, 2011 · SEC filing

Reported sold: $1
Investors reported: 136
Minimum accepted: $0
First sale: Apr 13, 2011

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Apr 22, 2011	Initial	$1	No comparison	136	SEC filing
Apr 22, 2011	Amendment	$1	$0vs Apr 22, 2011	136	SEC filing

Offering details

Securities: Other
Exemptions: 06
Duration over one year: No
Business combination: Yes

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-158807

Issuer, Algae Biosciences Corporation ("ABC") and Algae Biosciences Inc, a wholly owned subsidiary of Issuer ("ABI"), entered into a merger transaction wherein the outstanding securities of ABC were transferred to ABI in exchange for securities of Issuer.

exchange of stock for stock

Source: Form D, filed Apr 22, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Rakesh Amin	Director
Andrew D Ayers	Director, Executive
Kevin Blanchette	Director
Mark Edwards	Director
Glen Galster	Director
Keith Guelpa	Director
Lawrence Luke	Director
Jody Stachiw	Director
Robert J Thompson	Director, Executive

Issuer details

Industry: Other (See others in industry)

Address:

Suite 811 105 150 Crowfoot Crescent Nw
Calgary, A0, T3G 3T2